Cargando…
The Lung Microbiome in COPD and Lung Cancer: Exploring the Potential of Metal-Based Drugs
Chronic obstructive pulmonary disease (COPD) and lung cancer 17 are two of the most prevalent and debilitating respiratory diseases worldwide, both associated with high morbidity and mortality rates. As major global health concerns, they impose a substantial burden on patients, healthcare systems, a...
Autores principales: | O’Shaughnessy, Megan, Sheils, Orla, Baird, Anne-Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419288/ https://www.ncbi.nlm.nih.gov/pubmed/37569672 http://dx.doi.org/10.3390/ijms241512296 |
Ejemplares similares
-
The Role of Cancer Stem Cells in Drug Resistance in Gastroesophageal Junction Adenocarcinoma
por: Dinneen, Kate, et al.
Publicado: (2021) -
Bacterial microbiome of lungs in COPD
por: Sze, Marc A, et al.
Publicado: (2014) -
Lung and Gut Microbiome in COPD
por: Karakasidis, Efstathios, et al.
Publicado: (2023) -
The Role of Human Papilloma Virus in Dictating Outcomes in Head and Neck Squamous Cell Carcinoma
por: Brennan, Shane, et al.
Publicado: (2021) -
Inhaled Corticosteroids and the Lung Microbiome in COPD
por: Keir, Holly R., et al.
Publicado: (2021)